Fecal microbiota transplantation in recurrent Clostridium difficile infections. Framework and pharmaceutical preparation aspects;Le transfert de microbiote fécal lors d'infections récidivantes à Clostridium difficile. Cadre et aspects pharmacotechniques

Annales Pharmaceutiques Francaises

Volumn 73, Issue 5, 2015, Pages 323-331

  Batista, R ^a   Kapel, N ^b   Megerlin, F ^c   Chaumeil, J C ^d   Barbut, F ^e   Bourlioux, P ^f   Chast, F ^a  

^a Site Cochin   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c FACULTÉ DES SCIENCES PHARMACEUTIQUES ET BIOLOGIQUES   (France)

^d UNIV PARIS SUD   (France)

^e HÔPITAL SAINT ANTOINE   (France)

^f Laboratoire de Chimie Analytique et Electrochimie   (France)

Author keywords

Clostridium difficile infection; Fecal microbiota transplantation; Flora transplantation; Medication

Indexed keywords

BIOLOGICAL THERAPY; CLOSTRIDIUM DIFFICILE INFECTION; FECAL MICROBIOTA TRANSPLANTATION; FRANCE; HUMAN; RECURRENT INFECTION; REVIEW; TREATMENT RESPONSE; ENTEROCOLITIS, PSEUDOMEMBRANOUS; MICROBIOLOGY; MICROFLORA; PEPTOCLOSTRIDIUM DIFFICILE; PROCEDURES;

CLOSTRIDIUM DIFFICILE; ENTEROCOLITIS, PSEUDOMEMBRANOUS; FECAL MICROBIOTA TRANSPLANTATION; HUMANS; MICROBIOTA;

EID: 84940614587     PISSN: 00034509     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pharma.2015.02.004     Document Type: Review

References (29)

1. Zhang F., Luo W., Shi Y., Fan Z., Ji G. Should we standardize the 1700-year-old fecal microbiota transplantation?. Am J Gastroenterol 2012, 107:1755.
2. Eiseman B., Silen W., Bascom G.S., Kauvar A.J. Fecal enema as an adjunct in the treatment of pseudomembranous enterocolitis. Surgery 1958, 44(5):854-859.
3. van Nood E., Vrieze A., Nieuwdorp M., Fuentes S., Zoetendal E.G., de Vos W.M., et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med 2013, 368(5):407-415.
4. Fuentes S., van Nood E., Tims S., Heikamp-de Jong I., Ter Braak C.J., Keller J.J., et al. Reset of a critically disturbed microbial ecosystem: faecal transplant in recurrent Clostridium difficile infection. ISME J 2014, 8:1621-1633.
5. Surawicz C.M., Brandt L.J., Binion D.G., Ananthakrishnan A.N., Curry S.R., et al. Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections. Am J Gastroenterol 2013, 108:478-498. American Society of Gastroenterology.
6. Debast S.B., Bauer M.P., Kuijper E.J. European Society of Clinical Microbiology and Infectious Diseases: update of the treatment - guidance document for Clostridium difficile infection. Clin Microbiol Infect 2014, 20(Suppl 2):1-26.
7. FDA Guidance for industry - enforcement policy regarding investigational new drug requirements for use of fecal microbiota for transplantation to treat Clostridium difficile infection not responsive to standard therapies http://www.fda.gov/downloads/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/Vaccines/UCM361393.pdf.
8. Vrieze A., de Groot P.F., Kootte R.S., Knaapen M., van Nood E., Nieuwdorp M. Fecal transplant: a safe and sustainable clinical therapy for restoring intestinal microbial balance in human disease?. Best Pract Res Clin Gastroenterol 2013, 27:127-137.
9. Bourlioux P., Megerlin F., Corthier G., Gobert J.G., Butel M.J. Why could gut microbiota become a medication?. Ann Pharm Fr 2014, 72(5):325-329.
10. ANSM Rapport. La transplantation de microbiote fécal et son encadrement dans les essais cliniques 2014.
11. Smith M.B., Kelly C., Alm E.J. Policy: how to regulate faecal transplants. Nature 2014, 506:290-291.
12. Megerlin F., Fouassier E., Lopert R., Bourlioux P. Faecal microbiota transplantation: a sui generis biological drug, not a tissue. Ann Pharm Fr 2014, 72(4):217-220.
13. Megerlin F., Fouassier E. Le transfert de microbiote intestinal à finalité thérapeutique : quel droit applicable en France ?. Ann Pharm Fr 2014, 72(5):363-374.
14. Kassam Z., Lee C.H., Yuan Y., Hunt R.H. Fecal microbiota transplantation for Clostridium difficile infection: systematic review and meta-analysis. Am J Gastroenterol 2013, 108:500-508.
15. Louie T.J., Miller M.A., Mullane K.M., Weiss K., Lentnek A., Golan Y., et al. Fidaxomicin versus vancomycin for Clostridium difficile infection. N Engl J Med 2011, 364(5):422-431.
16. Gough E., Shaikh H., Manges A.R. Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection. Clin Infect Dis 2011, 53:994-1002.
17. Tibble J.A., Sigthorsson G., Foster R., Forgacs I., Bjarnason I. Use of surrogate markers of inflammation and Rome criteria to distinguish organic from nonorganic intestinal disease. Gastroenterology 2002, 123:450-460.
18. Bakken J.S., Borody T., Brandt L.J., Brill J.V., Demarco D.C., Franzos M.A., et al. Treating Clostridium difficile infection with fecal microbiota transplantation. Clin Gastroenterol Hepatol 2011, 9(12):1044-1049.
19. van Nood E., Speelman P., Nieuwdorp M., Keller J. Fecal microbiota transplantation: facts and controversies. Curr Opin Gastroenterol 2014, 30:34-39.
20. Smits L.P., Bouter K.E., de Vos W.M., Borody T.J., Nieuwdorp M. Therapeutic potential of fecal microbiota transplantation. Gastroenterology 2013, 145(5):946-953.
21. Afssaps Bonnes pratiques de préparation 2007.
22. Hamilton M.J., Weingarden A.R., Sadowsky M.J., Khoruts A. Standardized frozen preparation for transplantation of fecal microbiota for recurrent Clostridium difficile infection. Am J Gastroenterol 2012, 107(5):761-767.
23. Youngster I., Sauk J., Pindar C., Wilson R.G., Kaplan J.L., Smith M.B., et al. Fecal microbiota transplant for relapsing Clostridium difficile infection using a frozen inoculum from unrelated donors: a randomized, open-label, controlled pilot study. Clin Infect Dis 2014, 58(11):1515-1522.
24. Brandt L.J. American Journal of Gastroenterology lecture: intestinal microbiota and the role of fecal microbiota transplant (FMT) in treatment of C. difficile infection. Am J Gastroenterol 2013, 108:177-185.
25. Youngster I., Russell G.H., Pindar C., Ziv-Baran T., Sauk J., Hohmann E.L. Oral, capsulized, frozen fecal microbiota transplantation for relapsing Clostridium difficile infection. JAMA 2014, 10.1001/jama.2014.13875.
26. Dodin M., Katz D.E. Faecal microbiota transplantation for Clostridium difficile infection. Int J Clin Pract 2014, 68:363-368.
27. Rohlke F., Stollman N. Fecal microbiota transplantation in relapsing Clostridium difficile infection. Therap Adv Gastroenterol 2012, 5:403-420.
28. Owens C., Broussard E., Surawicz C. Fecal microbiota transplantation and donor standardization. Trends Microbiol 2013, 21:443-445.
29. Orenstein R., Griesbach C.L., DiBaise J.K. Moving fecal microbiota transplantation into the mainstream. Nutr Clin Pract 2013, 28:589-598.